Gene · 825
Papers1,501
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,501
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Reply to the Letter to the Editor on "The diagnosis of myotonic dystrophy type 2 in a patient with calpainopathy requires the determination of CCTG expansion" []. | Postep Psychiatr Neurol | 2025 | 40376290 | PubTator, text mining | PubMed |
| A survey on mutation spectrum in Iranian patients with limb-girdle muscular dystrophies. | Hum Genomics | 2025 | 40361203 | PubTator, text mining | PubMed |
| Urinary N-terminal titin fragment ascertained as biomarker in a small cohort of limb-girdle muscular dystrophy LGMDR1-calpain 3 related. | J Neuromuscul Dis | 2025 | 40356353 | PubTator, text mining | PubMed |
| Variants in CAPN3 Causing Autosomal Dominant Limb-Girdle Muscular Dystrophy Combined With Calpain-3 Deficiency. | Hum Mutat | 2025 | 40226307 | PubTator, text mining | PubMed |
| Identification of a pathogenic NHLRC1 variant in a consanguineous Pakistani family affected with severe and rapidly progressive Lafora disease. | Acta Epileptol | 2025 | 40217338 | PubTator, text mining | PubMed |
| RNA Mis-Splicing Effects of Noncanonical Splicing Variants in Limb-Girdle Muscular Dystrophy Type R1/2A. | Neurol Genet | 2025 | 40190443 | PubTator, text mining | PubMed |
| Treatabolome for finely targeting muscle pathology in LGMD. | Acta Myol | 2025 | 40183440 | PubTator, text mining | PubMed |
| Human tripartite motif-containing protein 71 NCL-1/HT2A/LIN-41 domain crystal structure and its potential natural inhibitors. | Int J Biol Macromol | 2025 | 40180090 | PubTator, text mining | PubMed |
| The Association Between Statin Drugs and Rhabdomyolysis: An Analysis of FDA Adverse Event Reporting System (FAERS) Data and Transcriptomic Profiles. | Genes (Basel) | 2025 | 40149400 | PubTator, text mining | PubMed |
| The Role of Integrin β1D Mislocalization in the Pathophysiology of Calpain 3-Related Limb-Girdle Muscular Dystrophy. | Cells | 2025 | 40136695 | PubTator, text mining | PubMed |
| Expanding ligand-receptor interaction networks for axon guidance: Structural insights into signal crosstalk and specificity. | Curr Opin Neurobiol | 2025 | 40117944 | PubTator, text mining | PubMed |
| A rare homozygous CAPN3 variant with distinct clinical features in unrelated families of Iraqi Jewish descent. | J Neuromuscul Dis | 2025 | 39973406 | PubTator, text mining | PubMed |
| Cellular mechanisms underlying overreaching in skeletal muscle following excessive high-intensity interval training. | Am J Physiol Cell Physiol | 2025 | 39903498 | PubTator, text mining | PubMed |
| The N-Terminal Fragment of Urine Titin Is Not a Product of Degradation by Calpain 3. | Muscle Nerve | 2025 | 39777416 | PubTator, text mining | PubMed |
| Human calpain-3 and its structural plasticity: Dissociation of a homohexamer into dimers on binding titin. | J Biol Chem | 2025 | 39725035 | PubTator, text mining | PubMed |
| Asymptomatic HyperCKemia in the Pediatric Population: A Prospective Study Utilizing Next-Generation Sequencing and Ancillary Tests. | Neurology | 2025 | 39666917 | PubTator, text mining | PubMed |
| The 21-base pair deletion mutant Calpain3 does not inhibit wild-type Calpain3 activity. | Genes Dis | 2025 | 39403691 | PubTator, text mining | PubMed |
| Pediatric Soft Tissue Sarcoma in Limb-Girdle Muscular Dystrophy: Molecular Findings and Clinical Implications. | Am J Case Rep | 2024 | 39733240 | PubTator, text mining | PubMed |
| Case report: A single novel calpain 3 gene variant associated with mild myopathy. | Front Genet | 2024 | 39703226 | PubTator, text mining | PubMed |
| Targeting KDM1A in Neuroblastoma with NCL-1 Induces a Less Aggressive Phenotype and Suppresses Angiogenesis. | J Clin Med | 2024 | 39458030 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/825/papers?page=3